In another postmortem analysis, ACE levels but not activity was reduced in the cerebrospinal fluid (CSF) of AD patients and correlated with increased Braak staging, a marker of topographic progression of AD (Miners et al., 2009). The gene discussed is ACE; the disease is Alzheimer disease.